NOT FOR DISTRIBUTION
Header cover image

Yestar Healthcare Holdings

Market Cap

HK$2.7b

Last Updated

2021/05/05 10:23 UTC

Data Sources

Company Financials +

Executive Summary

Yestar Healthcare Holdings Company Limited, an investment holding company, engages in the manufacture, distribution, and sale of medical imaging products in Mainland China. More Details


Snowflake Analysis

Slightly overvalued with imperfect balance sheet.

Share Price & News

How has Yestar Healthcare Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 2393 is less volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: 2393's weekly volatility (3%) has been stable over the past year.


Market Performance


7 Day Return

0%

2393

3.4%

HK Medical Equipment

-1.6%

HK Market


1 Year Return

-6.5%

2393

63.2%

HK Medical Equipment

27.1%

HK Market

Return vs Industry: 2393 underperformed the Hong Kong Medical Equipment industry which returned 71% over the past year.

Return vs Market: 2393 underperformed the Hong Kong Market which returned 28.4% over the past year.


Shareholder returns

2393IndustryMarket
7 Day0%3.4%-1.6%
30 Day0%20.7%-1.8%
90 Day-2.5%5.8%-2.6%
1 Year-6.5%-6.5%65.0%63.2%32.0%27.1%
3 Year-56.2%-57.1%236.7%221.9%4.7%-6.4%
5 Year-63.2%-64.7%386.9%342.7%59.5%32.5%

Long-Term Price Volatility Vs. Market

How volatile is Yestar Healthcare Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Yestar Healthcare Holdings undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 2393 (HK$1.15) is trading below our estimate of fair value (HK$11.59)

Significantly Below Fair Value: 2393 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 2393 is unprofitable, so we can't compare its PE Ratio to the HK Medical Equipment industry average.

PE vs Market: 2393 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 2393's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 2393's PB Ratio (3x) is in line with the HK Medical Equipment industry average.


Future Growth

How is Yestar Healthcare Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

11.1%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 2393's forecast earnings growth is above the savings rate (1.5%).

Earnings vs Market: Insufficient data to determine if 2393's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 2393's revenue (11.1% per year) is forecast to grow slower than the Hong Kong market (12.8% per year).

High Growth Revenue: 2393's revenue (11.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 2393's Return on Equity is forecast to be very high in 3 years time (42.5%).


Past Performance

How has Yestar Healthcare Holdings performed over the past 5 years?

-43.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 2393 is currently unprofitable.

Growing Profit Margin: 2393 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 2393 is unprofitable, and losses have increased over the past 5 years at a rate of 43.3% per year.

Accelerating Growth: Unable to compare 2393's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2393 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (19.7%).


Return on Equity

High ROE: 2393 has a negative Return on Equity (-75.41%), as it is currently unprofitable.


Financial Health

How is Yestar Healthcare Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 2393's short term assets (CN¥2.8B) do not cover its short term liabilities (CN¥3.3B).

Long Term Liabilities: 2393's short term assets (CN¥2.8B) exceed its long term liabilities (CN¥511.1M).


Debt to Equity History and Analysis

Debt Level: 2393's debt to equity ratio (192.4%) is considered high.

Reducing Debt: 2393's debt to equity ratio has increased from 46% to 192.4% over the past 5 years.

Debt Coverage: 2393's debt is well covered by operating cash flow (40.7%).

Interest Coverage: 2393 is unprofitable, therefore interest payments are not well covered by earnings.


Balance Sheet


Dividend

What is Yestar Healthcare Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 2393's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 2393's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 2393's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 2393's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: 2393 is not paying a notable dividend for the Hong Kong market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 2393's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.5yrs

Average management tenure


CEO

James Hartono (44 yo)

no data

Tenure

CN¥3,722,000

Compensation

Mr. James Hartono serves as the Chairman of The Board and Chief Executive Officer of Yestar Healthcare Holdings Company Limited (formerly known as Yestar International Holdings Company Limited). Mr. Harton...


CEO Compensation Analysis

Compensation vs Market: James's total compensation ($USD574.92K) is above average for companies of similar size in the Hong Kong market ($USD316.42K).

Compensation vs Earnings: James's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: 2393's management team is considered experienced (4.5 years average tenure).


Board Members

Experienced Board: 2393's board of directors are considered experienced (7.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Yestar Healthcare Holdings Company Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Yestar Healthcare Holdings Company Limited
  • Ticker: 2393
  • Exchange: SEHK
  • Founded: 1971
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: HK$2.705b
  • Shares outstanding: 2.35b
  • Website: https://www.yestarcorp.com

Number of Employees


Location

  • Yestar Healthcare Holdings Company Limited
  • Green Land Building
  • Floor 8, Block A
  • Shanghai
  • Shanghai Province
  • 201199
  • China

Listings


Biography

Yestar Healthcare Holdings Company Limited, an investment holding company, engages in the manufacture, distribution, and sale of medical imaging products in Mainland China. It operates through two segments...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/05 10:23
End of Day Share Price2021/05/05 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.